-
effectivehealthcare.ahrq.gov/products/pneumonia-antibiotic-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/products/chronic-pain-opioid-treatment/research
-
effectivehealthcare.ahrq.gov/products/hip-feature-treatment-future/research
-
effectivehealthcare.ahrq.gov/products/ischemic-stroke-treatment/technical-brief
-
effectivehealthcare.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research
-
effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment-future/research
-
effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/products/pressure-ulcer-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/products/sleep-apnea-treatment-future/research
-
effectivehealthcare.ahrq.gov/products/acute-pain-treatment/technical-brief
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - for those who either are initiating treatment with psychosocial therapies or who have not improved … on their current
therapy? … on their
current therapy? … on their current therapy? … on their
current therapy?
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - treatments? … This suggests a bias favoring rx
therapy, in my view. … Section Comment Response
Peer Reviewer
#7
Results p 83 L-23 Naïve statement: that combination therapy … treatments, especially for
preschoolers and adolescents. … on the overall benefit/risk of rx
treatments for ADHD.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - • Long-term oral hormone therapies reduce hip
and clinical fractures but increase multiple serious … While oral hormone
therapies for 5-7 years lowered both clinical and
hip fractures in women not selected … of anabolic
therapy followed by antiresorptive therapy, and
denosumab followed by bisphosphonate therapy … cycles of
osteoporosis drug therapy alternating with drug
holidays. … long-term bisphosphonates appeared
far greater than absolute increases in risk of
AFF and ONJ with these treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
September 01, 2016 - Comparing Talk Therapy and Other Depression Treatments With Antidepressant Medicines
Comparing Talk … Therapy and
Other Depression Treatments
With Antidepressant Medicines
A Review of the Research for … Talk therapy is a type of treatment in which you talk with a trained
therapist. … Only a few studies have been done on these other treatments as a
first treatment for depression. … Ask Your Health Care Professional
�Which treatment or combined treatments do you think may
be best
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-english-557a.pdf
June 02, 2025 - MODALITY] with the appropriate term: radiation therapy, drug
therapy, or cancer surgery. … Since it was decided that you would have [CANCER
TREATMENT MODALITY], did your [CANCER
TREATMENT MODALITY … , including the
treatments you did not get? … , including
the treatments you did not get? … , including the
treatments you did not get?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - Food and Drug Administration (FDA)-approved antiviral therapies for antiviral-
naïve adults with chronic … Need for studies not funded by pharmaceutical companies, as almost all studies of
antiviral therapies … The CER focused on current
FDA-approved antiviral therapies for antiviral-naïve adults with chronic … Need for studies not funded by pharmaceutical companies, as almost all studies of
antiviral therapies … acid sequence of the HCV non-structural 3-4A protease
domain
NCT01474811 HCV-TARGET: Hepatitis C
Therapeutic
-
www.ahrq.gov/sites/default/files/2024-04/yang-report.pdf
January 01, 2024 - Dedicated Treatment Management Systems (TMS)
are now managing all aspects of the patient RT treatments … This
study was designed to cover the cancer patients who received external beam radiation therapy
treatments … There are many types of potential
errors during radiation therapy treatments. … patient treatments could be detected automatically. … Not all radiation therapy (RT) treatment planning systems (TPS) are supported.
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-info-english-557-6a.docx
June 02, 2025 - MODALITY] with the appropriate term: radiation therapy, drug therapy, or cancer surgery. … Since it was decided that you would have [CANCER TREATMENT MODALITY], did your [CANCER TREATMENT MODALITY … ] team clearly explain how your cancer and [CANCER TREATMENT MODALITY] could affect your normal daily … In the last 6 months, did your [CANCER TREATMENT MODALITY] team tell you what the next steps in your … [CANCER TREATMENT MODALITY] would be?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - Since there are no
FDA approved treatments within the anti-sclerostin
monoclonal antibody class, Amgen … 2 referred to table 3 so that it didn’t imply that all the
listed harms were associated with these treatments … vertebral
fracture.2,4,6 Therefore, w hile drug holidays may be an option
for certain osteoporosis therapies … While
drug holidays may be an option for certain therapies,
DMB should not be discontinued without … Given that there
are no other treatments within the anti-sclerostin
monoclonal antibody class, this
-
digital.ahrq.gov/ahrq-funded-projects/feedback-treatment-intensification-data-reduce-cardiovascular-disease-risk/annual-summary/2010
January 01, 2010 - Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk - 2010 … Project Name
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk … Treatment intensification, the frequency with which clinicians appropriately increase pharmacotherapy … The linkage of process measures, such as treatment intensification to clinical benefit, is often supported … intensification in patients at high risk for CVD to improve rates of treatment intensification and to